|
Volumn 98, Issue 19, 2001, Pages 10833-10838
|
The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species
a c c a a c a a,b
c
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CASPASE;
CASPASE 3;
CASPASE 8;
CASPASE INHIBITOR;
CYTOCHROME C;
HISTONE DEACETYLASE INHIBITOR;
PROTEIN BCL 2;
PROTEIN BID;
REACTIVE OXYGEN METABOLITE;
UNCLASSIFIED DRUG;
VORINOSTAT;
APOPTOSIS;
ARTICLE;
CANCER CELL CULTURE;
CELL DEATH;
CONTROLLED STUDY;
DRUG CYTOTOXICITY;
DRUG MECHANISM;
ENZYME ACTIVATION;
ENZYME RELEASE;
GENE OVEREXPRESSION;
HUMAN;
HUMAN CELL;
MITOCHONDRIAL MEMBRANE;
OXIDATIVE STRESS;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
T CELL LEUKEMIA;
TRANSCRIPTION REGULATION;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN;
CARRIER PROTEINS;
CASPASE 10;
CASPASE 3;
CASPASE 8;
CASPASE 9;
CASPASES;
CYTOCHROME C GROUP;
ENZYME INHIBITORS;
GENE EXPRESSION;
HISTONE DEACETYLASES;
HUMANS;
HYDROXAMIC ACIDS;
PROTO-ONCOGENE PROTEINS C-BCL-2;
REACTIVE OXYGEN SPECIES;
TRANSCRIPTION, GENETIC;
TUMOR CELLS, CULTURED;
|
EID: 0035845541
PISSN: 00278424
EISSN: None
Source Type: Journal
DOI: 10.1073/pnas.191208598 Document Type: Article |
Times cited : (471)
|
References (39)
|